You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Details for Patent: 10,945,973


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,945,973
Title:Bupropion as a modulator of drug activity
Abstract: Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
Inventor(s): Tabuteau; Herriot (New York, NY)
Assignee: ANTECIP BIOVENTURES II LLC (New York, NY)
Application Number:16/983,873
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

United States Patent 10,945,973: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 10,945,973, titled "Bupropion as a modulator of drug activity," is a patent that discloses dosage forms, drug delivery systems, and methods related to the sustained release of dextromethorphan or improved therapeutic effects. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Title and Abstract

The patent, issued to unspecified inventors, focuses on the use of bupropion as a modulator to enhance the therapeutic effects of dextromethorphan. The abstract highlights the invention's aim to provide improved drug delivery systems and methods for sustained release, which can enhance the efficacy and safety of dextromethorphan-based treatments.

Scope of the Patent

Claim Analysis

The patent includes a series of claims that define the scope of the invention. Here are some key aspects:

Independent Claims

  • Claim 1: This claim typically sets the broadest scope of the invention, often describing the core components and their interactions. For example, it might claim a pharmaceutical composition comprising bupropion and dextromethorphan, along with specific dosage forms and delivery systems.
  • Claim 2-5: These claims usually narrow down the scope by adding specific limitations or additional components. For instance, they might specify the ratio of bupropion to dextromethorphan, the type of delivery system (e.g., sustained release tablets), or the method of administration.

Dependent Claims

  • Claims 6-10: These claims build upon the independent claims by adding further details or specific embodiments. They might include claims for different formulations, manufacturing processes, or specific therapeutic applications.

Claim Language and Scope Metrics

Research on patent scope metrics suggests that the length and count of independent claims can be indicative of the patent's breadth and complexity[3].

  • Independent Claim Length: Longer independent claims often indicate a more detailed and specific invention, which can be beneficial for clarity but may limit the scope.
  • Independent Claim Count: A higher number of independent claims can suggest a broader scope, as it covers more aspects of the invention.

Patent Claims and Their Implications

Patentability and Novelty

The claims must meet the criteria of novelty, non-obviousness, and utility to be patentable. The patent office would have evaluated these claims against prior art to ensure they are not obvious variants of existing inventions.

Obviousness and Prior Art

The patent office conducts an analysis to determine if the claimed invention is obvious in view of prior art. This involves comparing the claimed subject matter with existing patents and publications to ensure it represents a significant innovation[4].

Patent Landscape

Related Patents and Applications

To understand the broader patent landscape, it is essential to identify related patents and applications. Tools like the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD) can be used to find prior art and related patent families[4].

Global Dossier

This service provides access to the file histories of related applications from participating IP Offices, helping to identify the patent family and any office actions that may impact the validity or scope of the patent.

Common Citation Document (CCD)

The CCD consolidates prior art cited by all participating offices for the family members of a patent application, providing a comprehensive view of the prior art landscape.

Competitors and Market Impact

Analyzing the patent landscape also involves identifying competitors who may hold similar or overlapping patents. This can be done by searching patent databases and analyzing the patent portfolios of other companies in the pharmaceutical industry.

Legal and Regulatory Considerations

Patent Term Adjustments (PTA) and Terminal Disclaimers

Patents like US 10,945,973 may be subject to patent term adjustments (PTA) due to delays in the patent office's processing. However, any PTA must be considered in conjunction with terminal disclaimers, which can affect the patent's expiration date[1].

Small Claims Patent Court

In the context of patent disputes, the concept of a small claims patent court has been explored. Such a court could provide a more streamlined and cost-effective way to resolve patent infringement cases, which could impact the enforcement and defense of patents like US 10,945,973[2].

Key Takeaways

  • Scope and Claims: The patent's scope is defined by its claims, which must be novel, non-obvious, and useful.
  • Patent Landscape: Understanding related patents and applications is crucial for navigating the intellectual property landscape.
  • Legal Considerations: Patent term adjustments and terminal disclaimers can affect the patent's validity and expiration date.
  • Market Impact: The patent's impact on the market depends on its uniqueness, the presence of competitors, and the regulatory environment.

FAQs

What is the main focus of United States Patent 10,945,973?

The main focus of this patent is the use of bupropion as a modulator to enhance the therapeutic effects of dextromethorphan through improved drug delivery systems and methods.

How do patent scope metrics like independent claim length and count affect the patent?

These metrics can indicate the patent's breadth and complexity. Longer independent claims and a higher number of independent claims can suggest a more detailed and broader scope, respectively.

What tools can be used to search for related patents and prior art?

Tools such as the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD) are useful for finding related patents and prior art.

How do patent term adjustments (PTA) and terminal disclaimers impact a patent's expiration date?

PTA can extend the patent term due to delays in the patent office's processing, but any PTA must be considered in conjunction with terminal disclaimers, which can limit the extension beyond a specified date.

What is the potential impact of a small claims patent court on patent enforcement?

A small claims patent court could provide a more streamlined and cost-effective way to resolve patent infringement cases, which could simplify the enforcement and defense of patents.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO
  5. US10945973B2 - Bupropion as a modulator of drug activity - Google Patents

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,945,973

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Axsome AUVELITY bupropion hydrochloride; dextromethorphan hydrobromide TABLET, EXTENDED RELEASE;ORAL 215430-001 Aug 18, 2022 RX Yes Yes 10,945,973 ⤷  Try for Free DEXTROMETHORPHAN AND BUPROPION IN COMBINATION TO TREAT MAJOR DEPRESSIVE DISORDER ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,945,973

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014346807 ⤷  Try for Free
Australia 2015350559 ⤷  Try for Free
Australia 2018203638 ⤷  Try for Free
Australia 2019201548 ⤷  Try for Free
Australia 2019223187 ⤷  Try for Free
Australia 2019236614 ⤷  Try for Free
Australia 2019275593 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.